Visionaire Health Economics Study Comparing Economic Outcomes Between Visionaire and Standard Instrumentation
VISHE13
A Prospective, Randomised Pilot Study to Compare Health Economic Outcomes Using a Patient-matched Cutting Guide Versus Standard Instrumentation in Total Knee Arthroplasty.
1 other identifier
interventional
52
1 country
5
Brief Summary
The purpose and primary objective of this study is to compare health economic outcomes between the use of a patient-matched cutting guide (Visionaire) versus the use of standard instrumentation in Total Knee Arthroplasty(TKA). Data will be collected pre-operatively, intra-operatively and post operatively up until and including the six week post-operative assessment. The secondary objectives of the study are to compare safety and early readmission rates between the two techniques. The study hypothesis is that there is no difference in the cost of the episode of care from hospital admission to discharge, including pre-operative radiology costs and cost of resources, with the Visonaire patient-matched cutting guide compared to standard instrumentation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2014
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2014
CompletedFirst Posted
Study publicly available on registry
June 9, 2014
CompletedStudy Start
First participant enrolled
July 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2017
CompletedJanuary 8, 2019
January 1, 2019
2.9 years
June 5, 2014
January 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cost of the episode of care from admission to hospital to discharge
The cost of the episode of care from admission to hospital to discharge , including pre-operative radiology costs and costs associated with Visionaire and will incorporate the costs of time, number of instruments utilised, blood transfusion requirements, length of stay and pre-operative xray and MRI costs.
up to 1 week
Secondary Outcomes (1)
Percentage of patients that experience short term complications and/or early readmissions
up to 6 weeks
Study Arms (2)
TKA with standard instrumentation
NO INTERVENTIONThis arm consists of the Genesis II Total knee implant system or the Legion Primary total knee system with standard instrumentation
Total knee arthroplasty with Visionaire
ACTIVE COMPARATORThis arm will consist of the Genesis II Total Knee Implant System or Legion Primary Total Knee System with the Visionaire patient-matched instrumentation
Interventions
Patient Specific Instrumentation
Eligibility Criteria
You may qualify if:
- Degenerative arthritis of the knee requiring unilateral primary Total Knee Arthroplasty in subjects for whom the use of patient-matched cutting guides or standard instrumentation are, in the surgeon's opinion, clinically appropriate and acceptable forms of treatment;
- Patient is of legal age to consent and is skeletally mature;
- The patient is able to fully understand the purpose of the trial, and his/her role as a participant in the study
You may not qualify if:
- Patient is known to have poor bone stock making a Total Knee Arthroplasty unjustifiable.
- Patient is immuno-suppressed.
- Patient has physical, emotional or neurological conditions that would compromise the subject's compliance with postoperative rehabilitation and follow-up.
- Patient is pregnant or may become pregnant during the course of the study, or is lactating.
- Patient has a history of prior ipsilateral major knee surgery (e.g. arthroplasty, high tibial osteotomy, or tibial plateau fracture). Minor prior procedures such as Anterior Cruciate Ligament repair, meniscectomy, or arthroscopy are not excluded.
- Patient has active, localized or systemic infection.
- Patient is severely overweight (BMI \>40).
- Patient is a prisoner.
- Patient has had a total joint arthroplasty of the contralateral limb in the last 12 months.
- Patient presently identified with future need for bilateral TKA within the next twenty-four months.
- Patient has a known or suspected hypersensitivity/allergy to foreign materials contained in the implant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Life Bay View Hospital
Mossel Bay, Cape Town, 6506, South Africa
Sunninghill Hospital
Johannesburg, Gauteng, South Africa
Pretoria East Hospital
Pretoria, Gauteng, South Africa
Private Practice
Durban, KwaZulu-Natal, 4001, South Africa
Life Claremont Hospital
Cape Town, Western Cape, South Africa
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Baker
Private Practice
- PRINCIPAL INVESTIGATOR
Lieth Stewart
Life Claremont Hospital
- PRINCIPAL INVESTIGATOR
Willem Tollig
Pretoria East Hospital
- PRINCIPAL INVESTIGATOR
Michael Barrow
Sunninghill Hospital
- PRINCIPAL INVESTIGATOR
Dan Potgieter
Life Bay View Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2014
First Posted
June 9, 2014
Study Start
July 9, 2014
Primary Completion
May 15, 2017
Study Completion
May 15, 2017
Last Updated
January 8, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share